Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (7798)	11/24/1998 10:03:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

Seems many on Yahoo missing the point. Move in domicile is contemplated because company is planning for life after Neuprex is approved. Neuprex, IMO, may find much larger market than some posters who ignore the sepsis implications, think. Many U.S. corporations are registered in Delaware regardless of where they are located for tax and other motives. Many large pharmas have manufacturing plants in Puerto Rico mainly for tax purposes. I am therefore not opposed, but will read with care the information provided.